1. Home
  2. AMPH vs NEOG Comparison

AMPH vs NEOG Comparison

Compare AMPH & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • NEOG
  • Stock Information
  • Founded
  • AMPH 1996
  • NEOG 1981
  • Country
  • AMPH United States
  • NEOG United States
  • Employees
  • AMPH N/A
  • NEOG N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • NEOG Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • AMPH Health Care
  • NEOG Health Care
  • Exchange
  • AMPH Nasdaq
  • NEOG Nasdaq
  • Market Cap
  • AMPH 1.2B
  • NEOG 1.3B
  • IPO Year
  • AMPH 2014
  • NEOG 1989
  • Fundamental
  • Price
  • AMPH $26.05
  • NEOG $6.50
  • Analyst Decision
  • AMPH Buy
  • NEOG Buy
  • Analyst Count
  • AMPH 6
  • NEOG 4
  • Target Price
  • AMPH $35.17
  • NEOG $8.83
  • AVG Volume (30 Days)
  • AMPH 453.0K
  • NEOG 3.2M
  • Earning Date
  • AMPH 11-06-2025
  • NEOG 10-09-2025
  • Dividend Yield
  • AMPH N/A
  • NEOG N/A
  • EPS Growth
  • AMPH N/A
  • NEOG N/A
  • EPS
  • AMPH 2.27
  • NEOG N/A
  • Revenue
  • AMPH $723,305,000.00
  • NEOG $886,886,000.00
  • Revenue This Year
  • AMPH $0.74
  • NEOG N/A
  • Revenue Next Year
  • AMPH $5.63
  • NEOG $1.80
  • P/E Ratio
  • AMPH $11.48
  • NEOG N/A
  • Revenue Growth
  • AMPH N/A
  • NEOG N/A
  • 52 Week Low
  • AMPH $20.39
  • NEOG $3.87
  • 52 Week High
  • AMPH $46.43
  • NEOG $15.73
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 53.17
  • NEOG 58.90
  • Support Level
  • AMPH $23.67
  • NEOG $6.20
  • Resistance Level
  • AMPH $29.00
  • NEOG $6.72
  • Average True Range (ATR)
  • AMPH 1.38
  • NEOG 0.32
  • MACD
  • AMPH 0.24
  • NEOG 0.01
  • Stochastic Oscillator
  • AMPH 43.81
  • NEOG 77.35

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

Share on Social Networks: